Year |
Citation |
Score |
2015 |
Ramteke A, Ting H, Agarwal C, Mateen S, Somasagara R, Hussain A, Graner M, Frederick B, Agarwal R, Deep G. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Molecular Carcinogenesis. 54: 554-65. PMID 24347249 DOI: 10.1002/Mc.22124 |
0.525 |
|
2013 |
Mateen S, Raina K, Agarwal R. Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer. Nutrition and Cancer. 65: 3-11. PMID 23682778 DOI: 10.1080/01635581.2013.785004 |
0.562 |
|
2013 |
Mateen S, Raina K, Agarwal C, Chan D, Agarwal R. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. The Journal of Pharmacology and Experimental Therapeutics. 345: 206-14. PMID 23461975 DOI: 10.1124/Jpet.113.203471 |
0.602 |
|
2013 |
Deep G, Jain AK, Mateen S, Vijendra KC, Gangar SC, Agarwal C, Agarwal R. Abstract C73: Src-beta catenin-SNAI1 axis is critical for the stemness and bone metastasis of E-cadherin-lacking prostate cancer cells Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C73 |
0.549 |
|
2012 |
Mateen S, Raina K, Jain AK, Agarwal C, Chan D, Agarwal R. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics. 7: 1161-72. PMID 22965008 DOI: 10.4161/Epi.22070 |
0.629 |
|
2011 |
Mateen S, Gu M, Jain A, Agarwal C, Chan D, Agarwal R. Abstract 4592: Anti-tumorigenic effects of silibinin in combination with histone dacetylase inhibitors (TSA and SAHA): Involvement of G2/M arrest and apoptotic cell death Cancer Research. 71: 4592-4592. DOI: 10.1158/1538-7445.Am2011-4592 |
0.614 |
|
2010 |
Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Molecular Carcinogenesis. 49: 247-58. PMID 19908243 DOI: 10.1002/Mc.20595 |
0.609 |
|
2010 |
Mateen S, Raina K, Agarwal C, Agarwal R. Abstract 3796: Inhibition of epigenetic chromatin-modification enzymes: histone deacetylases and DNA methyltransferases by silibinin in human NSCLC H1299 cells Cancer Research. 70: 3796-3796. DOI: 10.1158/1538-7445.Am10-3796 |
0.613 |
|
Show low-probability matches. |